289 related articles for article (PubMed ID: 18789130)
1. Docosahexaenoic and eicosapentaenoic acids increase prion formation in neuronal cells.
Bate C; Tayebi M; Diomede L; Salmona M; Williams A
BMC Biol; 2008 Sep; 6():39. PubMed ID: 18789130
[TBL] [Abstract][Full Text] [Related]
2. Sequestration of free cholesterol in cell membranes by prions correlates with cytoplasmic phospholipase A2 activation.
Bate C; Tayebi M; Williams A
BMC Biol; 2008 Feb; 6():8. PubMed ID: 18269734
[TBL] [Abstract][Full Text] [Related]
3. The cellular prion protein with a monoacylated glycosylphosphatidylinositol anchor modifies cell membranes, inhibits cell signaling and reduces prion formation.
Bate C; Williams A
Prion; 2011; 5(2):65-8. PubMed ID: 21738009
[TBL] [Abstract][Full Text] [Related]
4. Squalestatin cures prion-infected neurons and protects against prion neurotoxicity.
Bate C; Salmona M; Diomede L; Williams A
J Biol Chem; 2004 Apr; 279(15):14983-90. PubMed ID: 14754889
[TBL] [Abstract][Full Text] [Related]
5. Glimepiride reduces the expression of PrPc, prevents PrPSc formation and protects against prion mediated neurotoxicity in cell lines.
Bate C; Tayebi M; Diomede L; Salmona M; Williams A
PLoS One; 2009 Dec; 4(12):e8221. PubMed ID: 20011040
[TBL] [Abstract][Full Text] [Related]
6. Glycosylphosphatidylinositol anchor analogues sequester cholesterol and reduce prion formation.
Bate C; Tayebi M; Williams A
J Biol Chem; 2010 Jul; 285(29):22017-26. PubMed ID: 20427265
[TBL] [Abstract][Full Text] [Related]
7. Cholesterol transporter ATP-binding cassette A1 (ABCA1) is elevated in prion disease and affects PrPC and PrPSc concentrations in cultured cells.
Kumar R; McClain D; Young R; Carlson GA
J Gen Virol; 2008 Jun; 89(Pt 6):1525-1532. PubMed ID: 18474570
[TBL] [Abstract][Full Text] [Related]
8. Docosahexaenoic and eicosapentaenoic acids increase neuronal death in response to HuPrP82-146 and Abeta 1-42.
Bate C; Marshall V; Colombo L; Diomede L; Salmona M; Williams A
Neuropharmacology; 2008 May; 54(6):934-43. PubMed ID: 18355880
[TBL] [Abstract][Full Text] [Related]
9. Sheep scrapie susceptibility-linked polymorphisms do not modulate the initial binding of cellular to disease-associated prion protein prior to conversion.
Rigter A; Bossers A
J Gen Virol; 2005 Sep; 86(Pt 9):2627-2634. PubMed ID: 16099922
[TBL] [Abstract][Full Text] [Related]
10. The glycosylphosphatidylinositol anchor is a major determinant of prion binding and replication.
Bate C; Tayebi M; Williams A
Biochem J; 2010 Apr; 428(1):95-101. PubMed ID: 20196773
[TBL] [Abstract][Full Text] [Related]
11. Prions amplify through degradation of the VPS10P sorting receptor sortilin.
Uchiyama K; Tomita M; Yano M; Chida J; Hara H; Das NR; Nykjaer A; Sakaguchi S
PLoS Pathog; 2017 Jun; 13(6):e1006470. PubMed ID: 28665987
[TBL] [Abstract][Full Text] [Related]
12. Monoacylated cellular prion protein modifies cell membranes, inhibits cell signaling, and reduces prion formation.
Bate C; Williams A
J Biol Chem; 2011 Mar; 286(11):8752-8. PubMed ID: 21212283
[TBL] [Abstract][Full Text] [Related]
13. Cholesterol depletion and modification of COOH-terminal targeting sequence of the prion protein inhibit formation of the scrapie isoform.
Taraboulos A; Scott M; Semenov A; Avrahami D; Laszlo L; Prusiner SB
J Cell Biol; 1995 Apr; 129(1):121-32. PubMed ID: 7698979
[TBL] [Abstract][Full Text] [Related]
14. Sialic Acid on the Glycosylphosphatidylinositol Anchor Regulates PrP-mediated Cell Signaling and Prion Formation.
Bate C; Nolan W; Williams A
J Biol Chem; 2016 Jan; 291(1):160-70. PubMed ID: 26553874
[TBL] [Abstract][Full Text] [Related]
15. Prion-induced neuronal damage--the mechanisms of neuronal destruction in the subacute spongiform encephalopathies.
Giese A; Kretzschmar HA
Curr Top Microbiol Immunol; 2001; 253():203-17. PubMed ID: 11417136
[TBL] [Abstract][Full Text] [Related]
16. Polyunsaturated fatty acids protect against prion-mediated synapse damage in vitro.
Bate C; Tayebi M; Salmona M; Diomede L; Williams A
Neurotox Res; 2010 Apr; 17(3):203-14. PubMed ID: 19644728
[TBL] [Abstract][Full Text] [Related]
17. Prion peptide 106-126 as a model for prion replication and neurotoxicity.
Singh N; Gu Y; Bose S; Kalepu S; Mishra RS; Verghese S
Front Biosci; 2002 Apr; 7():a60-71. PubMed ID: 11897566
[TBL] [Abstract][Full Text] [Related]
18. The AGAAAAGA palindrome in PrP is required to generate a productive PrPSc-PrPC complex that leads to prion propagation.
Norstrom EM; Mastrianni JA
J Biol Chem; 2005 Jul; 280(29):27236-43. PubMed ID: 15917252
[TBL] [Abstract][Full Text] [Related]
19. The multivesicular body is the major internal site of prion conversion.
Yim YI; Park BC; Yadavalli R; Zhao X; Eisenberg E; Greene LE
J Cell Sci; 2015 Apr; 128(7):1434-43. PubMed ID: 25663703
[TBL] [Abstract][Full Text] [Related]
20. A receptor for infectious and cellular prion protein.
Martins VR
Braz J Med Biol Res; 1999 Jul; 32(7):853-9. PubMed ID: 10454744
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]